The short answer
A specific increase in bleeding from turmeric with pirtobrutinib has not been established. Have concentrated supplements reviewed because the cancer medicine itself can cause bleeding or low platelets.
What this answer covers
Oral pirtobrutinib with turmeric products. Defined herbal preparations in aspirin studies are distinct from this cancer-drug pair.
- Supplement or preparation
- Curcuma longa
- Medication ingredient
- pirtobrutinib
Check the prescribed treatment
This review concerns oral pirtobrutinib tablets used for selected blood cancers. Pirtobrutinib is a reversible BTK inhibitor, and interaction findings or dose adjustments from other BTK medicines should not be copied to it. Keep your prescribed dosing and blood-count monitoring plan.
The human trial was largely negative
A randomized study tested defined Panax ginseng and turmeric preparations alone and with aspirin in healthy volunteers. Overall clotting and platelet measures were not meaningfully worsened, and no significant bleeding was reported. Some individual platelet-assay responses occurred, so the findings should not be described as proving no biological effect.
The preparation and population limit the conclusion
The turmeric preparation, dose and short trial duration do not represent every high-dose or absorption-enhanced product. The participants did not have cancer-treatment-related platelet problems. No exact combination trial was identified.
Use individualized precautions
Show the supplement and other medicines to the oncology team. Follow blood-count monitoring and report new bleeding or bruising promptly. Do not use the negative trial to override a low platelet count, and do not invent a dose gap or stop the cancer medicine yourself.
Evidence and practical considerations
Side effects & toxicity
The original bleeding claim is insufficient; a human trial with another drug was largely negative and does not establish target-pair safety.
- Exact scope
- Oral pirtobrutinib with turmeric products. Defined herbal preparations in aspirin studies are distinct from this cancer-drug pair. with RxNorm 2629338 IN pirtobrutinib. Exact current oral product: JAYPIRCA oral pirtobrutinib tablets. Salt, formulation and regimen distinctions explicit.
- Medication form and route
- Oral
What remains uncertain
- No exact combination outcome study; different-drug healthy-volunteer null retained. Exact botanical species and preparation matter.
Factors that may matter: Exact oral formulation and supplement preparation; Drug exposure versus clinical outcomes; Dose and duration; Platelet count and neurological symptoms.
Read the supporting source summaries
Source 1: Current original prescribing information
dailymed.nlm.nih.gov · Source check Sep 11, 2026
Population: Patients prescribed the exact oral formulation.
Bleeding/cytopenia warnings; strong inhibitor AUC increase 49% and strong inducer reduction 71%; product-specific management.
How this applies: RxNorm 2629338 IN pirtobrutinib. Exact current oral product: JAYPIRCA oral pirtobrutinib tablets. Salt, formulation and regimen distinctions explicit.
Exact product source, not a direct study of every supplement. Population, active metabolites and formulation scope retained.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 11, 2026
Population: 25 healthy volunteers allocated for each herbal preparation.
No clinically relevant overall platelet/coagulation effect or significant bleeding; occasional individual arachidonic-acid assay responses.
How this applies: Exact preparation/population/endpoints only; applicability to pirtobrutinib independently assessed.
Abstract-only exact formulations not fully characterized here. Different drug/population; turmeric is not isolated curcumin and P. ginseng is not American ginseng.
Source 3: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 11, 2026
Population: Terminology.
pirtobrutinib is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Sources checked and article drafted. |
Article revision: 71575aaf3440e179
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.